DELIVERING SUSTAINED GROWTH
We are diligently and sustainably achieving
excellence in all that we do
- home
- announcement
- 2021
- Received first approval in China from our India facility
- Started Phase III clinical trials for PCV
- Acquired 9 OTC brands
- Filed the first biosimilar with the European Medical Agency(EMA)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. I AcceptCookie policy 
